By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Alder Biopharmaceuticals Inc. 

Corporate Headquarters
11804 North Creek Parkway South
Bothell  Washington  98011  U.S.A.
Phone: 425-205-2900 Fax: 425-205-2901

Alder is revolutionizing the way antibody therapies are identified, selected, developed and produced. Our proprietary technologies make great strides possible in the field of antibody therapeutics, dramatically accelerating the way pharmaceutical and biotechnology companies bring new therapies to market.

Alder has developed two unique antibody technologies that together increase antibody potency, drastically accelerate production cycles, and lower overall production costs. These unique technologies--the Antibody Selection (ABS) System and our novel Mab Xpress® Antibody Production System--are cornerstones of our company and catalysts for change in the pharmaceutical industry.

Proprietary technology and a vision for the future of antibody therapeutics make Alder the ideal partner for leading pharmaceutical and biotechnology companies. Since inception, we have actively pursued strategic alliances with commercial and academic partners who share our goal of reducing the time and cost of developing superior antibodies for a range of unmet medical needs.

At Alder we seek talented contributors who thrive in a high-energy team environment and want to make a real and lasting impact in the field of antibody therapeutics. Alder teams are creative, collaborative, open, committed--and central to the success of this company and its mission. If this is the kind of company you want to work for, we want to hear from you.

Key Statistics

Ownership: Private

Web Site: Alder Biopharma


Company News
10 Biotech Stocks that Could Blow Up in Q3 7/6/2016 6:56:11 AM
Amgen (AMGN) Shows Off Mid-Stage Migraine Data, Needs to Compete With Eli Lilly (LLY), Teva (TEVA) and Alder Biopharma 6/9/2016 5:54:09 AM
Alder Biopharma Appoints Roger Cady, M.D., Vice President Of Neurology 6/6/2016 3:59:30 PM
Alder Biopharma To Hold Conference Call On Monday, March 28, At 8:30 Am ET 3/28/2016 8:01:20 AM
Alder Biopharma's Migraine Drug Meets Primary and Secondary Endpoints in Phase 2b Trial 3/28/2016 6:34:33 AM
Five Companies Face Big FDA Decisions This Month 3/14/2016 6:39:10 AM
Alder Biopharma Reports Fourth Quarter And Full Year 2015 Financial And Operating Results 2/24/2016 10:51:20 AM
Alder Biopharma Strengthens And Expands Leadership Team Supporting Advancement Of ALD403 Toward Future Commercialization 2/9/2016 8:02:21 AM
Alder Biopharma To Present At Leerink Partners 5th Annual Global Healthcare Conference 2/4/2016 7:53:42 AM
Alder Biopharma Reports Third Quarter 2015 Financial And Operating Results 11/6/2015 9:39:15 AM